| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825376 | Clinical Therapeutics | 2014 | 13 Pages |
Abstract
All rhPTH(1-34) doses appeared to be well tolerated in the population studied. Linear pharmacokinetic characteristics were displayed in the dose range studied. Chinese ClinicalTrials.gov identifier: ChiCTR-ONC-12002874.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yani MS, Chunxiao BS, Zhongfang BS, Jiali BS, Yongning MD, Yu MD, Fandian MD, Shaojun MD,